Two things stand out about U.S. business today. One is how successful U.S. firms are: they account for 57 of the world's 100 most valuable listed firms.
The other is the bad smell hanging over a number of powerful companies.
Boeing faces claims that it sold 737 Max planes with dangerous software. It says it is "taking actions to fully ensure the safety of the 737 Max."
Criminal charges have been filed against Goldman Sachs in Malaysia for its role in arranging $6.5 billion of debt for a state-run fund that engaged in fraud. Goldman says it is cooperating with investigators.
A jury in California found that Monsanto failed to warn a customer that its weedkiller could, allegedly, cause cancer. Bayer, a German firm which bought Monsanto in June, says it will appeal the verdict.
Wells Fargo, one of the United States' biggest banks, admitted creating 3.5 million unauthorized bank accounts. It says it is working to "rebuild trust with our stakeholders."
Facebook's data practices have come under scrutiny in several countries. The firm says "we need a more active role for governments and regulators."
Then there is the opioid epidemic, which involves not only Purdue Pharma, the maker of OxyContin, but also, according to a lawsuit by New York's attorney general, other firms including McKesson and Johnson & Johnson. Purdue says it is "deeply concerned" about opioid addiction. Last year McKesson also said it is "deeply concerned" by the epidemic and that its board has "enhanced oversight procedures." J&J says it is "committed to ensuring its medicines are used correctly."